Imagine enduring years of excruciating pain, heavy bleeding, and exhaustion, only to be left waiting for a simple procedure that could change your life. This is the stark reality for many women in Northern Ireland, where gynaecology waiting lists are the longest in the UK. But here's where it gets even more alarming: women like Elaine Gracey are being forced to suffer in silence, their symptoms dismissed as unimportant. And this is the part most people miss—the devastating impact of these delays on women's physical and mental health.
Elaine, now 50, was advised by her doctor over three years ago to have a coil fitted to manage her heavy and painful periods. Yet, she remains on a waiting list, her condition untreated. She vividly recalls a nightmarish experience: 'I was in so much pain I sat in the bath, which turned into a blood bath—passing clots the size of baby potatoes.' Despite her desperate need for relief, Elaine was expected to simply endure the bleeding. She resorted to sleeping with a towel on her sheets, exhausted from the pain and lack of sleep, yet still forced to go to work.
Northern Ireland's Department of Health acknowledges the issue, stating that 'significant work' is underway to reduce waiting times. But for women like Elaine, who has since been placed on a different form of hormone replacement therapy (HRT), the response feels inadequate. 'No woman should have to wait three or four years just to be called,' she says, her frustration palpable. 'That’s not dealing with the issue—we are just women.'
But here's the controversial part: while some argue that resource constraints are to blame, others question whether systemic neglect of women's health is the root cause. The Southern Trust has apologized for the 'significant distress' caused by long waits and is working to reduce delays with additional funding and clinics. Yet, the problem persists, with almost 60,000 women across the UK waiting to be seen or treated for gynaecological issues, according to the Royal College of Obstetricians and Gynaecologists.
The coil, a small device inserted into the womb, is often the first step in managing heavy bleeding during perimenopause and menopause. It acts as the progesterone component of HRT and can be fitted in just 5–10 minutes by a doctor or nurse. However, complications can arise, requiring hospital procedures. Despite its effectiveness, many women are left waiting, their symptoms worsening over time.
Take Gail Ritchie, 45, who waited over seven years for treatment after being diagnosed with pelvic congestion syndrome (PCS). 'I was in a very dark place, bleeding heavily, with a low mood—it was debilitating mentally and physically,' she recalls. After eight years, she opted for private treatment, paying £6,000 for a hysterectomy and HRT. 'The difference was night and day,' she says. 'For the first time, I felt listened to and heard.'
Dr. Charlie Beattie, an obstetrician and gynaecologist, describes the waiting times as 'extremely concerning.' He highlights the negative impact on women's physical and psychological well-being, as well as the broader societal consequences. 'Many women just struggle on with symptoms,' he notes, attributing this to acceptance, an inability to prioritize self-care, or challenges accessing services. He warns that delays in receiving HRT can increase long-term risks of osteoporosis, cardiovascular disease, and dementia.
Across Northern Ireland's health trusts, the situation is dire. Over 1,000 women are waiting to see a menopause specialist, with the longest waits reaching 160 weeks. While some trusts have established menopause clinics, others lack funding to do so. The Belfast Trust, once notorious for its long waits, has seen a positive drop after funding two consultant posts, but this remains an exception.
The Department of Health promises to reduce waiting lists and develop gynaecology-specific pathways, including menopause care. However, this work is still in its early stages and requires additional funding. But here's the question that lingers: How many more women will suffer before meaningful change is implemented? Is this a matter of resource allocation, or does it reflect a deeper societal undervaluing of women's health?
We want to hear from you. Do you think enough is being done to address these issues? Share your thoughts in the comments below—let’s spark a conversation that could drive real change.
